William Mezzanotte
Chief Tech/Sci/R&D Officer en CSL LIMITED .
Perfil
En la actualidad, William Mezzanotte es director médico, vicepresidente ejecutivo y jefe de I+D de CSL Ltd. El Dr. Mezzanotte también forma parte del consejo de BELLUS Health, Inc. y del University City Science Center. Anteriormente, el Dr. Mezzanotte fue Vicepresidente y Jefe de Respiración e Inflamación en AstraZeneca Plc y Vicepresidente Senior y Jefe del Área Terapéutica en C.H. Boehringer Sohn AG & Co. KG. William Mezzanotte se licenció en la Universidad de Villanova, se doctoró en la Universidad de Pensilvania y se graduó en la Universidad Johns Hopkins.
Cargos activos de William Mezzanotte
| Empresas | Cargo | Inicio |
|---|---|---|
| CSL LIMITED | Chief Tech/Sci/R&D Officer | 01/10/2018 |
University City Science Center
 University City Science Center Investment Trusts/Mutual FundsMiscellaneous University City Science Center provides physical space, resources and other support to the community. The company was founded in 1963 and is headquartered in Philadelphia, PA. | Director/Board Member | 19/06/2020 |
Antiguos cargos conocidos de William Mezzanotte.
| Empresas | Cargo | Fin |
|---|---|---|
| BELLUS HEALTH | Director/Board Member | 01/01/2023 |
C.H. Boehringer Sohn AG & Co. KG
 C.H. Boehringer Sohn AG & Co. KG Pharmaceuticals: MajorHealth Technology C.H. Boehringer Sohn AG & Co. KG operates as a holding company, with interests in the manufacturing of pharmaceutical products. It offers prescription drugs for the treatment of human respiratory, cardiovascular, gastrointestinal, and central nervous system diseases, including human immunodeficiency virus infection and cancer. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | Corporate Officer/Principal | 01/04/2017 |
| ASTRAZENECA PLC | Corporate Officer/Principal | 01/03/2015 |
CSL Behring LLC
 CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | Chief Tech/Sci/R&D Officer | - |
Formación de William Mezzanotte.
| University of Pennsylvania | Doctorate Degree |
| The Johns Hopkins University | Graduate Degree |
| Villanova University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| CSL LIMITED | Health Technology |
| Empresas privadas | 4 |
|---|---|
BELLUS Health, Inc.
 BELLUS Health, Inc. Pharmaceuticals: MajorHealth Technology BELLUS Health, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of cough hypersensitivity and other hypersensitization disorders. Its product BLU-5937, is being developed for the treatment of chronic cough and chronic pruritus, or chronic itch. The company was founded on June 17, 1993 and is headquartered in Laval, Canada. | Health Technology |
C.H. Boehringer Sohn AG & Co. KG
C.H. Boehringer Sohn AG & Co. KG Pharmaceuticals: MajorHealth Technology C.H. Boehringer Sohn AG & Co. KG operates as a holding company, with interests in the manufacturing of pharmaceutical products. It offers prescription drugs for the treatment of human respiratory, cardiovascular, gastrointestinal, and central nervous system diseases, including human immunodeficiency virus infection and cancer. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | Health Technology |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | Health Technology |
University City Science Center
University City Science Center Investment Trusts/Mutual FundsMiscellaneous University City Science Center provides physical space, resources and other support to the community. The company was founded in 1963 and is headquartered in Philadelphia, PA. | Miscellaneous |
- Bolsa de valores
- Insiders
- William Mezzanotte
